17 March 2021 in Respiration
Background: Bronchoscopic thermal vapour ablation (BTVA) is an established and approved modality for minimally invasive lung volume reduction in severe emphysema. Preclinical data suggest potential for BTVA in minimally invasive ablation of lung cancer lesions. Objectives: The objective of this study is to establish the safety, feasibility, and ablative efficacy of BTVA for minimally invasive ablation of lung cancers. Methods: Single arm treat-and-resect clinical feasibility study of patients with biopsy-confirmed lung cancer. A novel BTVA for lung cancer (BTVA-C) system for minimally invasive treatment of peripheral pulmonary tumours was used to deliver 330 Cal thermal vapour energy via bronchoscopy to target lesion. Patients underwent planned lobectomy to complete oncologic care. Pre-surgical CT chest and post-resection histologic analysis were performed to evaluate ablative efficacy. Results: Six patients underwent BTVA-C, and 5 progressed to planned lobectomy. Median procedure duration was 12 min. No major procedure-related complications occurred. All 5 resected lesions were part-solid lung adenocarcinomas with median solid component size 1.32±0.36 cm. Large uniform ablation zones were seen in 4 patients where thermal dose exceeded 3 Cal/mL, with complete/near-complete necrosis of target lesions seen in 2 patients. Tumour positioned within ablation zones demonstrated necrosis in >99% of cross-sectional area examined. Conclusion: BTVA of lung tumours is feasible and well tolerated, with preliminary evidence suggesting high potential for effective ablation of tumours. Thermal injury is well demarcated, and uniform tissue necrosis is observed within ablation zones receiving sufficient thermal dose per volume of lung. Treatment of smaller volumes and ensuring adequate thermal dose may be important for ablative efficacy.
31 January 2023 in Respiration
Background: Radiofrequency ablation (RFA) is an established modality for percutaneous ablation of non-small cell lung cancer (NSCLC) in medically inoperable patients but is underutilized clinically due to side effects. We have developed a novel, completely endobronchial RFA catheter with an externally cooled electrode. Objectives: The objective of this study was to establish the safety and feasibility of bronchoscopic RFA using a novel, externally cooled catheter for ablation of peripheral NSCLC. Methods: Patients with stage I biopsy-confirmed NSCLC underwent bronchoscopic RFA of tumour 7 days prior to lobectomy. The RFA catheter was delivered bronchoscopically to peripheral NSCLC lesions, guided by radial endobronchial ultrasound, with positioning confirmed using intra-procedural cone beam CT. Pre-operative CT chest and histologic examination of resected specimens were used to establish distribution/uniformity of ablation and efficacy of tumour ablation. Results: RFA in the first patient was complicated by dispersal of heated saline due to cough, resulting in ICU admission. The patient recovered fully and underwent uncomplicated lobectomy. Subsequently, the protocol was altered to mandate neuromuscular blockade with a pre-determined dose escalation, with algorithm-restricted energy (kJ) and irrigated saline volume (mL) constraints. A further 10 patients consented and seven underwent successful bronchoscopic RFA of peripheral NSCLC. No significant adverse events were noted. Ablation zone included tumour in all cases (proportion of tumour ablated ranged 8–72%), with uniform necrosis of tissue within ablation zones observed at higher energy levels. Ablation zone diameter correlated with RFA energy delivered (R2 = 0.553), with maximum long axis diameter of ablation zone 3.1 cm (22.9 kJ). Conclusion: Bronchoscopic RFA using an externally cooled catheter is feasible, appears safe, and achieves uniform ablation within the treatment zone. Uncontrolled escape of heated saline poses a major safety risk but can be prevented procedurally through neuromuscular blockade and by limiting irrigation.
1 May 2010 in Journal of Trauma: Injury, Infection & Critical Care
An intramedullary screw (Portland Orthopaedics, St. Clair, MI) and Inion (Tampere, Finland) Orthopaedic Trauma Plating System (OTPS) mesh for use for internal fixation of fractured ribs have not previously undergone biomechanical testing. The aim of this study is to compare the biomechanics of intact ribs undergoing four-point bending to the biomechanics of fractured ribs fixed with each of the two devices to determine which device provides superior fixation. Thirty fresh-frozen porcine ribs (ribs 6-8) were submitted to four-point bending to failure, at a rate of 2.5 mm/min, to determine stiffness and force at failure. The ribs were then randomized to receive fixation with either Inion OTPS mesh or an intramedullary screw. The fixated ribs were again submitted to four-point bending to failure. Ribs fixated with OTPS mesh were significantly stiffer and failed at a significantly higher load than ribs fixated with intramedullary screws (p = 0.0001). Ribs fixated with OTPS mesh were less stiff than intact ribs but failed at a similar force to intact ribs. The Inion OTPS mesh system provides superior fixation of fractured ribs compared with an intramedullary screw when tested with four-point bending. The OTPS mesh system also has the added advantage of being absorbable. The intramedullary screw needs to undergo modification and further testing before use in humans. Future studies should focus on more physiologic methods of loading.
26 May 2025 in Clinical Oncology
Clinical quality registries (CQRs) monitor the quality of healthcare by collecting, analysing and reporting benchmarked clinical quality performance outcomes to stakeholder institutions, with the objective of closing the research evidence-practice gap. Little is known of the effects of CQR function on clinical outcomes in lung cancer. We studied the attainment of 25 clinical quality indicators (CQIs), in consecutive, newly diagnosed lung cancer patients to assess longitudinal unwarranted clinical variation, quality indicator attainment and consequent survival impacts. This study was an observational cohort study of the Victorian Lung Cancer Registry in Victoria, Australia, between 2016 and 2021. We studied 12,121 consecutive patients, observing substantial variation in care in institutional indicator attainment for all indicators ranging from very low (2.1%) to high (90%) at study outset. Indicator attainment over time increased (n = 6 indicators), remained stable (n = 17), and decreased (n = 2). The attainment of CQI was associated with a significant reduction in mortality hazard for the majority of indicators (n = 15; HR reduced 10%-67%), and an increase in mortality hazard associated with 3 indicators (HR increased 32%-48%). Population level evaluation of indicators revealed multiple modifiable drivers that may be targeted to enhance indicator attainment. Non-small cell lung cancer (NSCLC) survival analysis identified significant improvement evident for stage II and IV NSCLC in the pre-COVID era and stage I overall. Clinical quality registries are potentially transformative tools for the definition and engagement of learning health systems in the healthcare quality improvement cycle. This study identified significant variation in hospital lung cancer CQI attainment and unwarranted variation between stakeholder sites. Stakeholder focus on this variation provides context-specific opportunity to identify local improvement opportunities. These process measures impact outcome measures, including survival, and enable the evaluation of the evidence-practice gap for service innovation and iterative quality improvement.
20 September 2018 in Journal of Medical Imaging and Radiation Oncology
Summary: Neurofibromatosis type 1 (NF1) is a multisystem phakomatosis. The intrathoracic manifestations of NF1 are protean. We describe a rare case of a plexiform neurofibroma infiltrating the mediastinum and lungs with multiple endobronchial neurofibromata. To our knowledge, a mediastinal plexiform neurofibroma extending into the lungs on CT has not been reported.
18 April 2021 in Anz Journal of Surgery